Applying a Modified Version of the Prediction of Alcohol Withdrawal Severity Scale in a Canadian Community Withdrawal Management Setting
Crepeault H, Cowan N, Socias ME, Riazi N, Knill A, Khela A, Wood E, Ti L., Drug Alcohol Rev. 2025
CRISM is a national network of researchers, service providers, policy makers, and people with lived experience of substance use. Its main goal is to translate evidence-based interventions into clinical practice, community prevention, harm reduction, and health system improvements. The aim is to support the creation of more effective, personalized, and adoptable programs and services.
Substance use disorders are pressing and complex health issues. Effective interventions require evidence-based approaches, an understanding of biological, psychosocial, and social factors, and recognition of the influence of cultural, societal, and policy contexts. While many intervention modalities have proven results, they are not yet widely implemented.
To address these translation and implementation gaps, the Canadian Institutes of Health Research (CIHR), through its Institute for Neurosciences, Mental Health, and Addiction (INMHA), developed the Canadian Research Initiative in Substance Matters (CRISM) (previously known as the Canadian Research Initiative in Substance Misuse). CRISM was designed to facilitate communication and collaboration across the pillars of addiction service providers, researchers, policy-makers, patients, and people who use substances. CRISM is a network that consists of five regional teams (referred to as Nodes), located in BC, the Prairies, Ontario, Québec, and the Atlantic region.
Provide evidence to support the enhancement of prevention and treatment services regarding substance use to decision makers and service providers
Identify and/or develop the most appropriate clinical and community-based interventions for substance use disorders
Support improvement in the quality of life for Canadians living with substance use
Crepeault H, Cowan N, Socias ME, Riazi N, Knill A, Khela A, Wood E, Ti L., Drug Alcohol Rev. 2025
Vieira JL, Coelho SG, Snaychuk LA, Tabri N, Dawson SJ, Hodgins DC, Keough MT, Shead NW, Kim HS., Cannabis, 2024
Rai U, Patte KA, Smith BT, Senthilselvan A, Hyshka E, Leatherdale ST, Pabayo R., Heliyon, 2024
Flores-Aranda J, Gaudette Y, Dalle A, Nadeau D, Goyette M. Int J Environ Res Public Health. 2024
Hines S.A., Morin A.J.S., Norman P., Read J.P., O’Connor R.M., Psychology of Addictive Behaviors, 2024
Reynolds A., Paige K.J., Colder C.R., Mushquash C.J., Wendt D.C., Burack J.A., O’Connor R.M., Research on Child and Adolescent Psychopathology, 2024
Tobias S, Bird J, Guzman SM, Palis H, Crabtree A, Hein JE, Wood E, Ti L., Canada. Int J Drug Policy. 2026
Socias ME, Lei J, Zhou V, Anand R, Cui Z, Penta S, Larochelle M, Lodi S, Fairbairn N., AMA Netw Open. 2026
Tobias S, Guzman SM, Hein JE, Ti L., Drug Alcohol Depend Rep. 2026
Mélanie Bédard, Erica Em Moodie, Joseph Cox, John Gill, Sharon Walmsley, Valérie Martel‑Laferrière, Curtis Cooper, Marina B Klein, Canadian Liver Journal, 2025
Karamouzian M, Cui Z, Hayashi K, DeBeck K, Reddon H, Buxton J, Kerr T, Int J Drug Policy
Bonn M, Kerr T, Boyd J, Rudzinski K, McNeil R, Ivsins A., Int J Drug Policy. 2025
Goodyear T, Thulien M, Anghel A, Slemon A, Jensen M, Ignaszewski MJ, Sassi R, Mathias S, Jenkins E, Knight R, Fast D. , Soc Sci Med. 2025
Ali, F., Law, J., Russell, C., Imtiaz, S., Bayoumi, A., Werb, D., Rhem, J., Front. Public Health
Jackson E, Bach P, Socias ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis BB., Drug Alcohol Depend. 2025
Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME., Subst Use Addctn J. 2025